Schedule 13G ownership disclosure

KESTRA MED TECHNOLOGIES LTD

Common Shares, par value $1.00 per share · CUSIP: G52441105

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Endeavour Medtech Growth II LP

    Shares: 2,448,942 · Class: 4.20%

  • Endeavour Medtech Growth II Parallel LP

    Shares: 2,448,942 · Class: 4.20%

  • Endeavour Medtech II GP Limited

    Shares: 2,448,942 · Class: 4.20%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-26-054535
Form type
SCHEDULE 13G/A
Filer
Endeavour Medtech Growth II LP
CIK
CIK 1873032
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub